Loading company details...
Beta
Latest Form 4 (Jun 15, 2026): David Scott Moore (Director): Purchase of 21,700 shares, $250.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 15, 2026 | David Scott Moore | Purchase | 21,700 | $250.2K |
| Jun 15, 2026 | Ian T. Clark | Grant/Award | 15,000 | n/a |
| Jun 15, 2026 | Linda Grais | Grant/Award | 15,000 | n/a |
| Jun 15, 2026 | Peter A. Thompson | Grant/Award | 15,000 | n/a |
| Jun 15, 2026 | Den Broek Richard Van | Grant/Award | 15,000 | n/a |
| May 20, 2026 | Richard A. Miller Md., President and CEO | Purchase | 5,000 | $60.3K |
| Apr 27, 2026 | Andrew C. Chan | Grant/Award | 30,000 | n/a |
| Jan 30, 2026 | Peter A. Thompson | Exercise/Conversion | 30,000 | $450.0K |
| Dec 8, 2025 | William Benton Jones, SVP, Pharmaceutical Development | Grant/Award | 400,000 | n/a |
| Dec 8, 2025 | Richard A. Miller Md., President and CEO | Grant/Award | 1,000,000 | n/a |